miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer

In the last decade, cancer research efforts in the field of noncoding microRNA (miRNA) have been growing exponentially. miRNA-based therapeutics have been tested in both preclinical and clinical settings, and miRNA-based cancer diagnostics and prognostics have moved into clinics to help better manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Fesler, Andrew, Zhai, Haiyan, Ju, Jingfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149397/
https://www.ncbi.nlm.nih.gov/pubmed/25187728
http://dx.doi.org/10.2147/OTT.S65548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149397/
https://www.ncbi.nlm.nih.gov/pubmed/25187728
http://dx.doi.org/10.2147/OTT.S65548

Ejemplares similares